Call Us: 1.800.873.5297


6.5 Million Dollar Jury Verdict in Actos® Trial

On April 26, 2013, a Los Angeles jury returned a verdict of $6.5 million to Jack Cooper, who was diagnosed with terminal bladder cancer after taking Actos® – manufactured by Takeda – for more than two years. The jury also awarded $1.5 million to Mr. Cooper’s wife for her loss of consortium claim. After more […]


Yahoo! News Reports on the NuvaRing® Multi-District Litigation

On April 26, 2013, Yahoo! News released an article regarding the NuvaRing® Multi-District Litigation (MDL) currently pending in the Eastern District of Missouri. In particular, the article reported that more than 1,000 women are suing the manufacturers of NuvaRing® alleging that NuvaRing® caused them to suffer serious – and sometimes fatal – blood clots. Plaintiffs […]


Federal Judge Denies NuvaRing® Daubert Motions and Allows Plaintiffs’ Experts to Proceed to Trial

Exciting developments have occurred for the benefit of all injured plaintiffs involved in the NuvaRing® Multi-District Litigation (MDL No. 1964). The Honorable Rodney W. Sippel has denied defendants’ Daubert Motions filed against several of plaintiffs’ expert witnesses. As a result, plaintiffs’ expert witnesses are allowed to testify at trial as to numerous issues, including defendants’ […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.